Eyal Reinstein, MD, PhD, DABMGG
About Eyal Reinstein, MD, PhD, DABMGG
Title: Chief Medical Officer
Eyal Reinstein, MD, PhD, DABMGG, serves as the Chief Medical Officer. In this key leadership role, Dr. Reinstein oversees medical strategy and operations, guiding clinical practice standards and ensuring the organization’s medical practices align with the latest research and advancements in genetics.
Education and Expertise in Biochemistry and Internal Medicine
Dr. Eyal Reinstein earned his PhD in biochemistry and his MD in internal medicine from the Technion-Israel Institute of Technology. His comprehensive background allows him to navigate complex medical challenges, bridging the gap between biochemical research and clinical application, particularly in the field of genetics.
Clinical Genetics Fellowship at UCLA
Dr. Reinstein completed a clinical genetics fellowship at the UCLA Medical Genetics Program. This advanced training helped him gain deep expertise in identifying and managing genetic disorders, equipping him with specialized skills essential for his subsequent roles in academic and clinical settings.
Academic and Clinical Leadership Roles
Eyal Reinstein has held significant positions in both academia and clinical practice. He served as the Director of the Department of Medical Genetics at Meir Medical Center in Israel and is an Associate Professor of Internal Medicine at Tel-Aviv University. His roles have involved extensive research, teaching, and administration, contributing to the advancement of genetic medicine.
Membership in the Helsinki Committee
From 2016 to 2021, Dr. Reinstein served as a member of both the Helsinki Committee of the Israel Ministry of Health and the Meir Medical Center. His contributions were integral to the oversight of medical research ethics, ensuring that clinical studies adhered to ethical standards and protected patient rights.
Authored Scientific Papers on Genetic Disorders
Dr. Eyal Reinstein has authored over 50 scientific papers that delineate novel genetic disorders and phenotypes. His research includes work on heritable connective tissue disorders, cardiac and eye abnormalities, and intellectual disability syndromes, adding to the collective understanding of these complex conditions.
Diplomate of the American Board of Medical Genetics and Genomics
Dr. Reinstein is recognized as a diplomate of the American Board of Medical Genetics and Genomics. This credential signifies his expertise and professional commitment to the field of genetics, validating his proficiency in diagnosing and managing genetic disorders.